• 872 Citations
  • 10 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile



Dr Varinder Jeet is a Research Fellow at the Macquarie University Centre for the Health Economy (MUCHE). Prior to joining MUCHE, Dr Jeet was a Postdoctoral Research Fellow at the Australian Prostate Cancer Research Centre, Queensland University of Technology (QUT) from 2010 to 2018 and a Research Officer at Mater Medical Research Institute, Brisbane from 2009-2010.


Varinder’s expertise lies in clinical/medical and health economics research. During his research career, Varinder has contributed to numerous research projects focussing on diagnosis, prognosis, and therapy. He generated and analysed data for two phase-1 prostate cancer clinical trials and discovered new mechanisms of cancer resistance and novel therapeutic approaches for advanced stages of cancer. He also discovered innovative techniques and biomarker panels for detecting cancer both at early and late stages of disease progression. As part of the high performing team at MUCHE, Varinder is currently contributing to Health Technology Assessments of new medicines and medical technologies.    

Varinder’s research has featured in high-quality scholarly periodicals such as Journal of Experimental Medicine, Clinical Chemistry, Scientific Reports, Cancer and Metastasis Reviews, Endocrine-Related Cancer, and others. He has successfully supervised two PhD students, delivered lectures to university students, and acted as a reviewer for peer-reviewed journals and NHMRC project grants. As a member of the Australian Society for Medical Research (ASMR) organising committee, Varinder helped in organising the ASMR conference annual dinner 2016. He has also served on career counselling, conference organisation and OH&S committees. In addition, Varinder has been the recipient of prestigious research grants, travel grants and other awards.   

Varinder has recently completed the Master of Health Economics degree to bridge the gap between clinical research and Health Technology Assessment (HTA). His broad knowledge of medical research areas and a solid educational background help him to understand the intricate processes of disease pathophysiology and ways to implement that knowledge in HTA procedures. Varinder is interested in economic modelling for therapeutic interventions, genetic testing/clinical genomics, cancer studies, and equity and public policy research.

Education/Academic qualification

Cancer Medicine, PhD in Medicine, The University of New South Wales

Health Economics, Master of Health Economics, The University of Queensland

Biotechnology, MSc, Punjabi University

Biomedical Sciences, BSc

External positions

Research Fellow, Queensland University of Technology


Research Officer, Mater Medical Research Institute (MMRI)


Fingerprint Dive into the research topics where Varinder Jeet is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Outputs

  • 872 Citations
  • 10 h-Index
  • 14 Meeting abstract
  • 10 Article
  • 4 Review article
  • 1 Chapter

Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)

Yeh, M. C., Tse, B. W. C., Fletcher, N. L., Houston, Z. H., Lund, M., Volpert, M., Stewart, C., Sokolowski, K. A., Jeet, V., Thurecht, K. J., Campbell, D. H., Walsh, B. J., Nelson, C. C. & Russell, P. J., 7 May 2020, In : EJNMMI Research. 10, 13 p., 46.

Research output: Contribution to journalArticle

Open Access
  • Emergence of microRNAs as key players in cancer cell metabolism

    Subramaniam, S., Jeet, V., Clements, J. A., Gunter, J. H. & Batra, J., 1 Sep 2019, In : Clinical Chemistry. 65, 9, p. 1090-1101 12 p.

    Research output: Contribution to journalReview article

  • 13 Citations (Scopus)

    Interleukin (IL)-22 from IL-20 subfamily of cytokines induces colonic epithelial cell proliferation predominantly through ERK1/2 pathway

    Moniruzzaman, M., Wang, R., Jeet, V., McGuckin, M. A. & Hasnain, S. Z., 15 Jul 2019, In : International Journal of Molecular Sciences. 20, 14, p. 1-17 17 p., 3468.

    Research output: Contribution to journalArticle

    Open Access
  • 2 Citations (Scopus)
    4 Downloads (Pure)

    MicroRNA-3162-5p-mediated crosstalk between Kallikrein family members including prostate-specific antigen in prostate cancer

    Australian Prostate Cancer BioResource, Mating, F., Jeet, V., Srinivasan, S., Cristino, A. S., Panchadsaram, J., Clements, J. A. & Batra, J., Jun 2019, In : Clinical Chemistry. 65, 6, p. 771-780 10 p.

    Research output: Contribution to journalArticle

    5 Citations (Scopus)

    A biomarker and a therapeutic target: investigating the role of glypican-1 in prostate cancer

    Jeet, V., Rockstroh, A., Yeh, M-C., Campbell, D. H., Walsh, B. J., Russell, P. J. & Nelson, C. C., Aug 2018, In : BJU International. 122, S2, p. 36-37 2 p., 084.

    Research output: Contribution to journalMeeting abstract


  • Commercialisation of Pharmaceutical Research

    Varinder Jeet (Recipient), 2018

    Prize: Other distinction

  • Finalist

    Varinder Jeet (Recipient), 2007

    Prize: Other distinction

  • Activities

    • 2 Publication Peer-review
    • 1 Invited talk

    Biomedicine and Pharmacotherapy (Journal)

    Varinder Jeet (Reviewer)

    Activity: Publication peer-review and editorial workPublication Peer-review

    PLoS ONE (Journal)

    Varinder Jeet (Reviewer)

    Activity: Publication peer-review and editorial workPublication Peer-review

    Australian Canadian Prostate Cancer Research Alliance Meeting

    Varinder Jeet (Speaker)
    2008 → …

    Activity: Talk or presentationInvited talk

    Press / Media

    Fundraising for Prostate Cancer Research

    Varinder Jeet


    1 Media contribution

    Press/Media: Public Engagement Activities


    Improving health and spending money wisely: evaluating medicines and vaccines for the Australian Government

    Henry Cutler (Participant), Bonny Parkinson (Participant), Martin Hoyle (Participant), Mutsa Gumbie (Participant), Rachel Song (Participant), Andrew Partington (Participant), Varinder Jeet (Participant), Elizabeth Seil (Participant), Alicia Norman (Participant), Virginia Mumford (Participant), Sanjyot Vagholkar (Participant), Lisa Pont (Participant), Janaki Amin (Participant)

    Impact: Quality of life impacts, Economic impacts, Public policy impacts